KMTS — Kestra Medical Technologies Balance Sheet
0.000.00%
Last trade - 00:00- $1.20bn
- $1.18bn
- $27.81m
Annual balance sheet for Kestra Medical Technologies, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2020 April 30th | 2021 April 30th | 2023 April 30th | 2024 April 30th | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 5.76 | 24.3 | 14.8 | 8.25 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | — | — | 0 | 2 |
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 6.17 | 26.2 | 18.4 | 14.9 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 1.13 | 3.08 | 16.7 | 28.4 |
| Other Long Term Assets | ||||
| Total Assets | 7.87 | 30.5 | 38.7 | 45.9 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 4.02 | 6.61 | 36.7 | 33 |
| Long Term Debt | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 4.02 | 28.8 | 54.1 | 78.2 |
| Redeemable Preferred Stock | ||||
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | 3.86 | 1.77 | -15.5 | -32.3 |
| Total Liabilities & Shareholders' Equity | 7.87 | 30.5 | 38.7 | 45.9 |
| Total Common Shares Outstanding |